Summary

HNY Research projects that the Embolization Particle market size will grow from 2685.66 Million USD in 2025 to 6815.33 Million USD by 2031, at an estimated CAGR of 16.79%. The base year considered for the study is 2025, and the market size is projected from 2026 to 2031.
For 2025 regional market size, the North America market size was 573.66 Million USD, the Europe market size was 384.86 Million USD, and the Asia market size was 545.46 Million USD.
This report presents a detailed and holistic analysis of the global Embolization Particle market. It integrates quantitative data with qualitative insights to equip readers with the necessary information for strategic planning, competitive assessment, market positioning, and data-driven decision-making.
All market sizes, estimates, and forecasts are expressed in terms of output/shipments and revenue. With 2025 serving as the base year, the report provides historical context from 2020. and projections up to 2031. It includes a complete segmentation of the global market, along with regional market sizes analyzed by type, application, and key industry participants.
Further enriching the analysis, the report outlines the competitive environment, offering profiles of prominent players and their market standings. It also explores key technological advancements and recent developments in product offerings.
Ultimately, this report serves as a vital resource for Embolization Particle manufacturers, prospective entrants, and other stakeholders within the industry value chain. It supplies comprehensive data on revenues, production, and average pricing for the overall market and its sub-segments, detailed by company, product type, application, and geographic region.

By Market Players:
Sirtex Medical
Merit Medical
Cook Medical
BTG Medical
Boston Scientific Corporation
Terumo Corporation
HENGRUI Medical
INterface BIOmaterials B.V.
Alicon

By Type
Microspheres
Particles (e.g. PVA Particles, Gelfoam Particles)
Drug-eluting Beads (DEBs)
Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)

By Application
Uterine Fibroid Embolization
Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
Liver Tumor Embolization
Trauma Embolization
Others

By Regions/Countries:
North America
East Asia
Europe
South Asia
Southeast Asia
Middle East
Africa
Oceania
South America

Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Embolization Particle Revenue
1.4 Market Analysis by Type
1.4.1 Global Embolization Particle Market Size Growth Rate by Type: 2026-2031
1.4.2 Microspheres
1.4.3 Particles (e.g. PVA Particles, Gelfoam Particles)
1.4.4 Drug-eluting Beads (DEBs)
1.4.5 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
1.5 Market by Application
1.5.1 Global Embolization Particle Market Share by Application: 2026-2031
1.5.2 Uterine Fibroid Embolization
1.5.3 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
1.5.4 Liver Tumor Embolization
1.5.5 Trauma Embolization
1.5.6 Others
1.6 Study Objectives
1.7 Overview of Global Embolization Particle Market
1.7.1 Global Embolization Particle Market Status and Outlook (2020-2031)
1.7.2 North America
1.7.3 East Asia
1.7.4 Europe
1.7.5 South Asia
1.7.6 Southeast Asia
1.7.7 Middle East
1.7.8 Africa
1.7.9 Oceania
1.7.10 South America
1.7.11 Rest of the World
2 Manufacturing Cost Structure Analysis
2.1 Manufacturing Cost Structure Analysis of Embolization Particle
2.2 Industry Chain Structure of Embolization Particle
3 Market Competition by Manufacturers
3.1 Global Embolization Particle Production Capacity Market Share by Manufacturers (2020-2025)
3.2 Global Embolization Particle Revenue Market Share by Manufacturers (2020-2025)
3.3 Global Embolization Particle Average Price by Manufacturers (2020-2025)
4 Embolization Particle Regional Market Analysis
4.1 Embolization Particle Production by Regions
4.1.1 Global Embolization Particle Production by Regions (2020-2025)
4.1.2 Global Embolization Particle Revenue by Regions
4.2 Embolization Particle Consumption by Regions
4.3 North America Embolization Particle Market Analysis
4.3.1 North America Embolization Particle Production
4.3.2 North America Embolization Particle Revenue
4.3.3 Key Manufacturers in North America
4.3.4 North America Embolization Particle Import and Export
4.4 East Asia Embolization Particle Market Analysis
4.4.1 East Asia Embolization Particle Production
4.4.2 East Asia Embolization Particle Revenue
4.4.3 Key Manufacturers in East Asia
4.4.4 East Asia Embolization Particle Import & Export
4.5 Europe Embolization Particle Market Analysis
4.5.1 Europe Embolization Particle Production
4.5.2 Europe Embolization Particle Revenue
4.5.3 Key Manufacturers in Europe
4.5.4 Europe Embolization Particle Import & Export
4.6 South Asia Embolization Particle Market Analysis
4.6.1 South Asia Embolization Particle Production
4.6.2 South Asia Embolization Particle Revenue
4.6.3 Key Manufacturers in South Asia
4.6.4 South Asia Embolization Particle Import & Export
4.7 Southeast Asia Embolization Particle Market Analysis
4.7.1 Southeast Asia Embolization Particle Production
4.7.2 Southeast Asia Embolization Particle Revenue
4.7.3 Key Manufacturers in Southeast Asia
4.7.4 Southeast Asia Embolization Particle Import & Export
4.8 Middle East Embolization Particle Market Analysis
4.8.1 Middle East Embolization Particle Production
4.8.2 Middle East Embolization Particle Revenue
4.8.3 Key Manufacturers in Middle East
4.8.4 Middle East Embolization Particle Import & Export
4.9 Africa Embolization Particle Market Analysis
4.9.1 Africa Embolization Particle Production
4.9.2 Africa Embolization Particle Revenue
4.9.3 Key Manufacturers in Africa
4.9.4 Africa Embolization Particle Import & Export
4.10 Oceania Embolization Particle Market Analysis
4.10.1 Oceania Embolization Particle Production
4.10.2 Oceania Embolization Particle Revenue
4.10.3 Key Manufacturers in Oceania
4.10.4 Oceania Embolization Particle Import & Export
4.11 South America Embolization Particle Market Analysis
4.11.1 South America Embolization Particle Production
4.11.2 South America Embolization Particle Revenue
4.11.3 Key Manufacturers in South America
4.11.4 South America Embolization Particle Import & Export
5 Embolization Particle Sales Market by Type (2020-2031)
5.1 Global Embolization Particle Historic Market Size by Type (2020-2025)
5.2 Global Embolization Particle Forecasted Market Size by Type (2026-2031)
6 Embolization Particle Consumption Market by Application(2020-2031)
6.1 Global Embolization Particle Historic Market Size by Application (2020-2025)
6.2 Global Embolization Particle Forecasted Market Size by Application (2026-2031)
7 Company Profiles and Key Figures in Embolization Particle Business
7.1 Sirtex Medical
7.1.1 Sirtex Medical Company Profile
7.1.2 Sirtex Medical Embolization Particle Product Specification
7.1.3 Sirtex Medical Embolization Particle Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.2 Merit Medical
7.2.1 Merit Medical Company Profile
7.2.2 Merit Medical Embolization Particle Product Specification
7.2.3 Merit Medical Embolization Particle Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.3 Cook Medical
7.3.1 Cook Medical Company Profile
7.3.2 Cook Medical Embolization Particle Product Specification
7.3.3 Cook Medical Embolization Particle Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.4 BTG Medical
7.4.1 BTG Medical Company Profile
7.4.2 BTG Medical Embolization Particle Product Specification
7.4.3 BTG Medical Embolization Particle Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.5 Boston Scientific Corporation
7.5.1 Boston Scientific Corporation Company Profile
7.5.2 Boston Scientific Corporation Embolization Particle Product Specification
7.5.3 Boston Scientific Corporation Embolization Particle Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.6 Terumo Corporation
7.6.1 Terumo Corporation Company Profile
7.6.2 Terumo Corporation Embolization Particle Product Specification
7.6.3 Terumo Corporation Embolization Particle Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.7 HENGRUI Medical
7.7.1 HENGRUI Medical Company Profile
7.7.2 HENGRUI Medical Embolization Particle Product Specification
7.7.3 HENGRUI Medical Embolization Particle Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.8 INterface BIOmaterials B.V.
7.8.1 INterface BIOmaterials B.V. Company Profile
7.8.2 INterface BIOmaterials B.V. Embolization Particle Product Specification
7.8.3 INterface BIOmaterials B.V. Embolization Particle Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.9 Alicon
7.9.1 Alicon Company Profile
7.9.2 Alicon Embolization Particle Product Specification
7.9.3 Alicon Embolization Particle Production Capacity, Revenue, Price and Gross Margin (2020-2025)
8 Production and Supply Forecast
8.1 Global Forecasted Production of Embolization Particle (2026-2031)
8.2 Global Forecasted Revenue of Embolization Particle (2026-2031)
8.3 Global Forecasted Price of Embolization Particle (2020-2031)
8.4 Global Forecasted Production of Embolization Particle by Region (2026-2031)
8.4.1 North America Embolization Particle Production, Revenue Forecast (2026-2031)
8.4.2 East Asia Embolization Particle Production, Revenue Forecast (2026-2031)
8.4.3 Europe Embolization Particle Production, Revenue Forecast (2026-2031)
8.4.4 South Asia Embolization Particle Production, Revenue Forecast (2026-2031)
8.4.5 Southeast Asia Embolization Particle Production, Revenue Forecast (2026-2031)
8.4.6 Middle East Embolization Particle Production, Revenue Forecast (2026-2031)
8.4.7 Africa Embolization Particle Production, Revenue Forecast (2026-2031)
8.4.8 Oceania Embolization Particle Production, Revenue Forecast (2026-2031)
8.4.9 South America Embolization Particle Production, Revenue Forecast (2026-2031)
8.4.10 Rest of the World Embolization Particle Production, Revenue Forecast (2026-2031)
8.5 Forecast by Type and by Application (2026-2031)
8.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2026-2031)
8.5.2 Global Forecasted Consumption of Embolization Particle by Application (2026-2031)
9 Consumption and Demand Forecast
9.1 North America Forecasted Consumption of Embolization Particle by Country
9.2 East Asia Market Forecasted Consumption of Embolization Particle by Country
9.3 Europe Market Forecasted Consumption of Embolization Particle by Countriy
9.4 South Asia Forecasted Consumption of Embolization Particle by Country
9.5 Southeast Asia Forecasted Consumption of Embolization Particle by Country
9.6 Middle East Forecasted Consumption of Embolization Particle by Country
9.7 Africa Forecasted Consumption of Embolization Particle by Country
9.8 Oceania Forecasted Consumption of Embolization Particle by Country
9.9 South America Forecasted Consumption of Embolization Particle by Country
9.10 Rest of the world Forecasted Consumption of Embolization Particle by Country
10 Marketing Channel, Distributors and Customers
10.1 Marketing Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities and Drivers
11.3 Challenges
11.4 Porter's Five Forces Analysis
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer